Interestingly, TB treatment activated multiple immune-related pathways, including TRAF6-mediated NF-κB induction, IRF7 activation via TLR7/8 or TLR9, TRIF-mediated TLR4 signaling, and MyD88-dependent and -independent cascades. This evidence concerns the gene NFKB1 and tuberculosis.